US Broker Ratings

Encompass Health Corporation (EHC) Stock Analysis: Unpacking a 32.55% Potential Upside

Investors in Encompass Health Corporation (NYSE: EHC) might find themselves at an intriguing crossroads as they consider the potential trajectory of this healthcare giant. Specializing in inpatient rehabilitation services, Encompass..

Waters Corporation (WAT) Investor Outlook: Navigating a 11.88% Potential Upside in the Diagnostics & Research Space

Waters Corporation (NYSE: WAT), a pivotal player in the healthcare sector, specifically within the diagnostics and research industry, offers intriguing prospects for individual investors. With a robust market capitalization of..

Agilent Technologies, Inc. (A) Stock Analysis: Exploring a Potential 38.98% Upside for Savvy Investors

Agilent Technologies, Inc. (NYSE: A) stands as a formidable player in the healthcare sector, prominently situated in the diagnostics and research industry. With a market capitalization of $32.67 billion, Agilent..

Bio-Techne Corp (TECH) Stock Analysis: Exploring a 29.52% Potential Upside Amidst Market Volatility

Bio-Techne Corp (NASDAQ: TECH), a prominent player in the healthcare sector’s biotechnology industry, offers a compelling investment opportunity with a potential upside of 29.52%. With a market capitalization of $7.57..

Exact Sciences Corporation (EXAS): Investor Outlook on This Healthcare Innovator’s 23.1% Revenue Growth

Exact Sciences Corporation (NASDAQ: EXAS), a leader in the healthcare sector, is gaining traction among investors for its innovative contributions to cancer diagnostics and research. Headquartered in Madison, Wisconsin, the..

BeOne Medicines Ltd. (ONC) Stock Analysis: A 31.77% Upside Potential Powers Investor Optimism

For investors keen on the biotechnology sector, BeOne Medicines Ltd. (ONC) represents a compelling opportunity with significant upside potential. Based in Basel, Switzerland, this oncology-focused biotech firm boasts a robust..

DexCom, Inc. (DXCM) Stock Analysis: 37.83% Potential Upside Captivates Investors

DexCom, Inc. (DXCM) stands as a prominent player in the healthcare sector, specializing in the innovative realm of medical devices. This San Diego-based company has carved out a niche in..

Corcept Therapeutics (CORT) Stock Analysis: Unveiling a 40% Potential Upside in the Biotech Sector

Corcept Therapeutics Incorporated (NASDAQ: CORT), a leading biopharmaceutical company, is capturing the attention of investors with its significant potential upside. With a market capitalization of $5.61 billion, this biotechnology firm..

Cencora, Inc. (COR) Stock Analysis: A 36.74% Potential Upside in the Healthcare Sector

Cencora, Inc. (COR), with a robust market capitalization of $50.8 billion, stands as a formidable player in the healthcare sector, specifically in medical distribution. This Conshohocken, Pennsylvania-based company, formerly known..

Solventum Corporation (SOLV) Stock Analysis: Strong ROE and 10.5% Upside Potential Drive Investor Interest

Solventum Corporation (NASDAQ: SOLV), a burgeoning player in the healthcare sector, offers a unique investment opportunity characterized by its diverse portfolio and robust financial metrics. With a market capitalization of..

Waystar Holding Corp. (WAY) Investor Outlook: A Potential 62% Upside Amid Robust Revenue Growth

Waystar Holding Corp. (NASDAQ: WAY) is capturing investor attention with its impressive potential upside of 62.48%, based on its average target price of $34.74. As a key player in the..

Zoetis Inc. (ZTS) Stock Analysis: An Impressive 64.26% Potential Upside Catches Investor Attention

Zoetis Inc. (NYSE: ZTS), a leading player in the animal health industry, has captured investor interest with its substantial potential upside of 64.26%. As a premier company in the healthcare..

Henry Schein, Inc. (HSIC) Stock Analysis: Unveiling a 23.15% Potential Upside for Investors

Henry Schein, Inc. (NASDAQ: HSIC) stands as a prominent player in the healthcare sector, specifically within the medical distribution industry. With a substantial market capitalization of $8.07 billion, this U.S.-based..

McKesson Corporation (MCK) Stock Analysis: Analyst Ratings Signal 30% Upside Potential for Healthcare Giant

For investors looking to strengthen their portfolios with a robust player in the healthcare sector, McKesson Corporation (NYSE: MCK) presents a compelling opportunity. With its extensive operations in medical distribution..

ResMed Inc. (RMD) Stock Analysis: A Leading Healthcare Player with 30% Upside Potential

ResMed Inc. (NYSE: RMD), a prominent figure in the healthcare sector, continues to cement its position as a key player in the medical instruments and supplies industry. With a market..

Chemed Corp (CHE) Stock Analysis: Navigating the Healthcare Sector with a 5.24% Potential Upside

Chemed Corporation (NYSE: CHE), a key player in the healthcare sector, operates on two fronts through its VITAS and Roto-Rooter segments. While VITAS provides essential hospice and palliative care services,..

Align Technology, Inc. (ALGN) Stock Analysis: Unlocking 23.87% Potential Upside with a Strong Buy Consensus

Align Technology, Inc. (NASDAQ: ALGN) stands out in the healthcare sector as a key player in the medical instruments and supplies industry. Known for its innovative Invisalign clear aligners and..

Hologic, Inc. (HOLX) Stock Analysis: Steady Growth with Limited Upside Potential

Hologic, Inc. (NASDAQ: HOLX), a major player in the healthcare sector, stands out in the medical instruments and supplies industry with a robust market capitalization of $16.97 billion. As a..

Koninklijke Philips N.V. (PHG) Stock Analysis: Assessing a 24% Upside Potential in the Healthcare Sector

As an established player in the healthcare sector, Koninklijke Philips N.V. (NYSE: PHG) presents intriguing opportunities for investors navigating the medical devices industry. With its headquarters in Amsterdam, the Netherlands,..

Avantor, Inc. (AVTR) Stock Analysis: Evaluating Growth Potential Amidst a 19.41% Upside

Avantor, Inc. (AVTR), a key player in the healthcare sector, stands out as an intriguing investment opportunity in the medical instruments and supplies industry. With a market capitalization of $5.67..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds